title: Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey.
abstract: BACKGROUND
  Although fever and hypothermia are common abnormal physical signs observed in patients admitted to intensive care units (ICU), little data exist on their optimal management. The objective of this study was to describe contemporary practices and determinants of management of temperature abnormalities among patients admitted to ICUs.
  
  
  METHODS
  Site leaders of the multi-national EUROBACT study were surveyed regarding diagnosis and management of temperature abnormalities among patients admitted to their ICUs.
  
  
  RESULTS
  Of the 162 ICUs originally included in EUROBACT, responses were received from 139 (86%) centers in 23 countries in Europe (117), South America (8), Asia (5), North America (4), Australia (3) and Africa (2). A total of 117 (84%) respondents reported use of a specific temperature threshold in their ICU to define fever. A total of 14 different discrete levels were reported with a median of 38.2°C (inter-quartile range, IQR, 38.0°C to 38.5°C). The use of thermometers was protocolized in 91 (65%) ICUs and a wide range of methods were reportedly used, with axillary, tympanic and urinary bladder sites as the most common as primary modalities. Only 31 (22%) of respondents indicated that there was a formal written protocol for temperature control among febrile patients in their ICUs. In most or all cases practice was to control temperature, to use acetaminophen, and to perform a full septic workup in febrile patients and that this was usually directed by physician order. While reported practice was to treat nearly all patients with neurological impairment and most patients with acute coronary syndromes and infections, severe sepsis and septic shock, this was not the case for most patients with liver failure and fever.
  
  
  CONCLUSIONS
  A wide range of definitions and management practices were reported regarding temperature abnormalities in the critically ill. Documenting temperature abnormality management practices, including variability in clinical care, is important to inform planning of future studies designed to optimize infection and temperature management strategies in the critically ill.
authors: Daniel J
authors: DJ
authors: Niven
authors: Kevin B
authors: KB
authors: Laupland
authors: Alexis
authors: A
authors: Tabah
authors: Aurélien
authors: A
authors: Vesin
authors: Jordi
authors: J
authors: Rello
authors: Despoina
authors: D
authors: Koulenti
authors: George
authors: G
authors: Dimopoulos
authors: Jan
authors: J
authors: de Waele
authors: Jean-Francois
authors: JF
authors: Timsit
mesh_terms: D000082:Acetaminophen / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D058633:Antipyretics / Q000627:therapeutic use; D016470:Bacteremia / Q000175:diagnosis; D002985:Clinical Protocols; D005334:Fever / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007035:Hypothermia / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D007036:Hypothermia, Induced; D007362:Intensive Care Units; D013821:Thermometers
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D058633:Antipyretics; D000082:Acetaminophen